RG 7697

Drug Profile

RG 7697

Alternative Names: MAR-709; RG7697

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Marcadia Biotech
  • Developer Roche
  • Class Antihyperglycaemics; Peptides
  • Mechanism of Action Gastric inhibitory polypeptide receptor agonists; Glucagon like peptide 1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 29 Jul 2015 Discontinued - Phase-II for Type-2 diabetes mellitus in USA (unspecified route)
  • 03 Dec 2014 Phase-II clinical trials in Type-2 diabetes mellitus in USA (unspecified route)
  • 18 Oct 2012 Phase-I clinical trials in Type-2 Diabetes mellitus in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top